These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29108961)

  • 1. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
    Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Lauraine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA;
    Eur J Surg Oncol; 2019 Jan; 45(1):67-74. PubMed ID: 29108961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New clinical research strategies for rare gynecologic malignancies.
    Ray-Coquard I; Pujade-Lauraine E; Ledermann JA
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):53-7. PubMed ID: 25490380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
    Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
    Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges.
    Ledermann JA; Ray-Coquard I
    Am Soc Clin Oncol Educ Book; 2014; ():e282-6. PubMed ID: 24857114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours.
    Laskaratos FM; Caplin M
    Eur J Surg Oncol; 2019 Jan; 45(1):52-59. PubMed ID: 29685756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment challenges in and outside a network setting: Head and neck cancers.
    Orlandi E; Alfieri S; Simon C; Trama A; Licitra L;
    Eur J Surg Oncol; 2019 Jan; 45(1):40-45. PubMed ID: 29478741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
    Mathoulin-Pélissier S; Pritchard-Jones K
    Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving treatment results with reference centres for rare cancers: where do we stand?
    Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
    Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
    Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
    Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours.
    Leary AF; Quinn M; Fujiwara K; Coleman RL; Kohn E; Sugiyama T; Glasspool R; Ray-Coquard I; Colombo N; Bacon M; Zeimet A; Westermann A; Gomez-Garcia E; Provencher D; Welch S; Small W; Millan D; Okamoto A; Stuart G; Ochiai K;
    Ann Oncol; 2017 Apr; 28(4):718-726. PubMed ID: 27993794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.
    Nicolai N; Biasoni D; Catanzaro MA; Colecchia M; Trama A;
    Eur J Surg Oncol; 2019 Jan; 45(1):60-66. PubMed ID: 29526370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.
    Ferrari A; Brecht IB; Gatta G; Schneider DT; Orbach D; Cecchetto G; Godzinski J; Reguerre Y; Bien E; Stachowicz-Stencel T; Ost M; Magni C; Kearns P; Vassal G; Massimino M; Biondi A; Bisogno G; Trama A
    Eur J Cancer; 2019 Mar; 110():120-126. PubMed ID: 30785015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies.
    Boussios S; Zarkavelis G; Seraj E; Zerdes I; Tatsi K; Pentheroudakis G
    Anticancer Res; 2016 Oct; 36(10):5031-5042. PubMed ID: 27798862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.
    Lykoudis PM; Partelli S; Muffatti F; Caplin M; Falconi M; Fusai GK;
    Eur J Surg Oncol; 2019 Jan; 45(1):46-51. PubMed ID: 29126671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.